ENG and hepatocellular carcinoma: The 2-year survival rate of HCC patients with a lower CD105-MVD (< 56, the median value) was 47.1%, which was significantly higher than the 13.5% rate of HCC patients with a higher CD105-MVD (P = 0.014; Fig. 4A).